Major Pharmaceuticals Announces Retirement and Transition Plan for Michael Redd
Livonia, MI, July 31, 2010 --(PR.com)-- Major Pharmaceuticals a leading national supplier of generic over the counter pharmaceuticals today announced that Michael Redd will step down as President on August 7, 2010 for personal reasons. Redd will be succeeded by Thomas Larkin, formerly Chief Strategic Officer of The Harvard Drug Group, parent company of Major Pharmaceuticals.
"This was a very tough and personal decision for me," said Redd. "It has been a great decade for me and I have made many friendships along the way. However, I am excited about spending more time with my wife and family. Major Pharmaceuticals is well-positioned for success. I remain fully committed to the company and will serve as a consultant in the coming months to ensure that a smooth transition occurs," said Redd.
"Over the last two years I have worked closely with Tom on numerous strategic and operational initiatives and am confident the company will continue to grow and prosper under his leadership."
"For the past nine years, Mike has personified creativity, dedication and drive. With this spirit, he has led his team passionately. Mike will be missed, and I wish him well in all of his future endeavors," said Randolph J. Friedman, Chairman and Chief Executive Officer of The Harvard Drug Group LLC, parent company of Major Pharmaceuticals.
In his new role as President, Thomas Larkin will lead all functions of the company, including sales, marketing, product launch and operations.
"I am excited about the opportunity to lead Major Pharmaceuticals and I am looking forward to working with a great team and furthering the growth of the company," said Larkin.
Larkin joined The Harvard Drug Group as the company’s Chief Strategic Officer in October 2008. Prior to that, he served over ten years in various leadership roles providing expertise to areas including sales operations and marketing within the generic pharmaceutical industry.
"Major Pharmaceuticals is a wonderful company and has a wonderful future. Tom has a proven track record of providing exceptional vision and leadership and will continue to drive growth for the company in his new role as President of Major Pharmaceuticals," said Friedman.
About Major Pharmaceuticals
Founded in 1991, Major Pharmaceuticals (Majorpharmaceuticals.com) is a leading national supplier of Rx pharmaceuticals, Unit Dose and over-the-counter drugs. The company offers products equivalent to national brands in quality, formula, size and structure, for a fraction of the cost. The company sells to over 6,000 customers, including wholesalers, distributors, government agencies, hospitals, long term care companies and chain drug stores. The company is headquartered in Livonia, Michigan.
###
"This was a very tough and personal decision for me," said Redd. "It has been a great decade for me and I have made many friendships along the way. However, I am excited about spending more time with my wife and family. Major Pharmaceuticals is well-positioned for success. I remain fully committed to the company and will serve as a consultant in the coming months to ensure that a smooth transition occurs," said Redd.
"Over the last two years I have worked closely with Tom on numerous strategic and operational initiatives and am confident the company will continue to grow and prosper under his leadership."
"For the past nine years, Mike has personified creativity, dedication and drive. With this spirit, he has led his team passionately. Mike will be missed, and I wish him well in all of his future endeavors," said Randolph J. Friedman, Chairman and Chief Executive Officer of The Harvard Drug Group LLC, parent company of Major Pharmaceuticals.
In his new role as President, Thomas Larkin will lead all functions of the company, including sales, marketing, product launch and operations.
"I am excited about the opportunity to lead Major Pharmaceuticals and I am looking forward to working with a great team and furthering the growth of the company," said Larkin.
Larkin joined The Harvard Drug Group as the company’s Chief Strategic Officer in October 2008. Prior to that, he served over ten years in various leadership roles providing expertise to areas including sales operations and marketing within the generic pharmaceutical industry.
"Major Pharmaceuticals is a wonderful company and has a wonderful future. Tom has a proven track record of providing exceptional vision and leadership and will continue to drive growth for the company in his new role as President of Major Pharmaceuticals," said Friedman.
About Major Pharmaceuticals
Founded in 1991, Major Pharmaceuticals (Majorpharmaceuticals.com) is a leading national supplier of Rx pharmaceuticals, Unit Dose and over-the-counter drugs. The company offers products equivalent to national brands in quality, formula, size and structure, for a fraction of the cost. The company sells to over 6,000 customers, including wholesalers, distributors, government agencies, hospitals, long term care companies and chain drug stores. The company is headquartered in Livonia, Michigan.
###
Contact
Major Pharmaceuticals
Jennifer Glenfield
(734) 743-6409
majorpharmaceuticals.com
Jennifer Glenfield
(734) 743-6409
majorpharmaceuticals.com
Contact
Categories